Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS)
by
Alzamzami, Waseem
, Alatawi, Sael
in
Analysis
/ B cells
/ Biology and Life Sciences
/ Cancer
/ Care and treatment
/ Cross-Sectional Studies
/ Crosstalk
/ Data analysis
/ Data processing
/ Deregulation
/ Diagnosis
/ Disease
/ Ethics
/ Female
/ Gene expression
/ Gene Expression Profiling
/ Genes
/ Health aspects
/ Health services
/ Humans
/ Immunomodulation
/ Immunoregulation
/ Investigations
/ Kinases
/ Male
/ Medicine and Health Sciences
/ Metabolism
/ Metabolomics
/ Myelodysplastic syndrome
/ Myelodysplastic syndromes
/ Myelodysplastic Syndromes - genetics
/ Myelodysplastic Syndromes - metabolism
/ Myelodysplastic Syndromes - therapy
/ Oncology, Experimental
/ Pathogenesis
/ Physiological aspects
/ Prognosis
/ Protein interaction
/ Protein Interaction Maps
/ Protein-protein interactions
/ Proteins
/ Retrospective Studies
/ Stem cells
/ Survival
/ Survival analysis
/ Therapeutic targets
/ Transcriptome
/ Transcriptomics
/ Up-regulation
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS)
by
Alzamzami, Waseem
, Alatawi, Sael
in
Analysis
/ B cells
/ Biology and Life Sciences
/ Cancer
/ Care and treatment
/ Cross-Sectional Studies
/ Crosstalk
/ Data analysis
/ Data processing
/ Deregulation
/ Diagnosis
/ Disease
/ Ethics
/ Female
/ Gene expression
/ Gene Expression Profiling
/ Genes
/ Health aspects
/ Health services
/ Humans
/ Immunomodulation
/ Immunoregulation
/ Investigations
/ Kinases
/ Male
/ Medicine and Health Sciences
/ Metabolism
/ Metabolomics
/ Myelodysplastic syndrome
/ Myelodysplastic syndromes
/ Myelodysplastic Syndromes - genetics
/ Myelodysplastic Syndromes - metabolism
/ Myelodysplastic Syndromes - therapy
/ Oncology, Experimental
/ Pathogenesis
/ Physiological aspects
/ Prognosis
/ Protein interaction
/ Protein Interaction Maps
/ Protein-protein interactions
/ Proteins
/ Retrospective Studies
/ Stem cells
/ Survival
/ Survival analysis
/ Therapeutic targets
/ Transcriptome
/ Transcriptomics
/ Up-regulation
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS)
by
Alzamzami, Waseem
, Alatawi, Sael
in
Analysis
/ B cells
/ Biology and Life Sciences
/ Cancer
/ Care and treatment
/ Cross-Sectional Studies
/ Crosstalk
/ Data analysis
/ Data processing
/ Deregulation
/ Diagnosis
/ Disease
/ Ethics
/ Female
/ Gene expression
/ Gene Expression Profiling
/ Genes
/ Health aspects
/ Health services
/ Humans
/ Immunomodulation
/ Immunoregulation
/ Investigations
/ Kinases
/ Male
/ Medicine and Health Sciences
/ Metabolism
/ Metabolomics
/ Myelodysplastic syndrome
/ Myelodysplastic syndromes
/ Myelodysplastic Syndromes - genetics
/ Myelodysplastic Syndromes - metabolism
/ Myelodysplastic Syndromes - therapy
/ Oncology, Experimental
/ Pathogenesis
/ Physiological aspects
/ Prognosis
/ Protein interaction
/ Protein Interaction Maps
/ Protein-protein interactions
/ Proteins
/ Retrospective Studies
/ Stem cells
/ Survival
/ Survival analysis
/ Therapeutic targets
/ Transcriptome
/ Transcriptomics
/ Up-regulation
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS)
Journal Article
New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS)
2024
Request Book From Autostore
and Choose the Collection Method
Overview
The metabolomic landscape in myelodysplastic syndrome (MDS) is highly deregulated and presents promising avenues for understanding disease pathogenesis and potential molecular dependencies. Here, we evaluated the transcriptomic landscape in MDS in multiple independent studies focusing more on metabolomics pathways. Identifying molecular dependencies will pave the way for a more precise disease stratification as well as the development of novel personalized treatment strategies. The study adopted a retrospective, cross-sectional approach, utilizing transcriptomic data from multiple MDS studies. The transcriptomic data were then subjected to comprehensive analyses, including differential gene expression, gene enrichment analysis, gene co-expression analysis, protein-protein interaction analyses, and survival analyses. PSAT1 showed a significant upregulation profile in MDS patients. This observed upregulation is correlated with the deregulation of immune-related pathways in MDS samples. This observation suggests a novel role for PSAT1 in immune modulation and potentially in augmenting immune evasion, which may lead to poor prognosis. This was evident in other tumors in the TCGA database, where cancer patients with high PSAT1 expression have a shorter overall survival. This study unveils a novel potential therapeutic avenue in MDS. Identifying the role of the PSAT1 gene sheds light on the disease’s intricate biology, highlighting the ongoing cross-talk between metabolism and immune regulation, which may pave the way for innovative treatment modalities.
Publisher
Public Library of Science,Public Library of Science (PLoS)
This website uses cookies to ensure you get the best experience on our website.